Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is devel.
NanoXplore Inc. is pleased to announce it has closed its previously announced bought deal offering of 6,522,00 Common Shares from treasury at a price of $4.60 per Common Share for aggregate gross proceeds of $30,001,200 . The Offering was conducted by a syndicate of underwriters co-led by National Bank Financial Inc. and Canaccord Genuity Corp., and which included Echelon Wealth Partners Inc., Raymond James Ltd., .
NanoXplore Inc. is issuing this press release to comment on recent trading activity of its stock. The Company announces that it is not aware of any material, undisclosed corporate developments and has no material change to report currently. The Company is also unaware of any material undisclosed change related to the Company that would explain the recent movements in the price of its common shares. The Company will .